Scientific Program

PROGRAM OBJECTIVES

After this Symposium, participants will be able to:

  • Recognize the relevance of the tumor microenvironment as it pertains to non-Hodgkin’s lymphoma.
  • Discuss the biologic predictors and implications on treatment in follicular lymphoma.
  • Discuss the role of stem cell transplantation in follicular lymphoma.
  • Review the emerging pathways and associated targeted treatment options for patients with Hodgkin disease.
  • Demonstrate knowledge on the treatment strategies available for patients with mantle cell lymphoma.
  • Evaluate the available treatment options for patients with newly diagnosed chronic lymphocytic leukemia.

SCIENTIFIC PROGRAM


Friday,
April 17, 2009

12:00 - 17:00
Registration Open

Session I
Translational/Pathology

13:00 - 13:15
Welcome and Overview

13:15 - 14:00
Ken Cohen, MD
University of Chicago
NHL microenvironment

14:00 - 14:45
Eric Hsi, MD
Cleveland Clinic
Biologic predictors and implications on treatment in follicular lymphoma

14:45 - 15:05
Break

15:05 - 15:50
Andrew Evens, DO, MS
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Rational Pathways to Target in Hodgkin lymphoma

15:50 - 16:35
Neil Kay, MD
Mayo Clinic
Novel Approaches and Agents for the Treatment of CLL

16:35 - 17:35
Sonali Smith, MD
University of Chicago
Poster Discussion & Reception

Saturday, April 18, 2009

07:00 - 15:00
Registration Open

07:00 - 08:00
Breakfast

Session II
Clinical

08:00 - 08:45
James Cerhan, MD
Mayo Clinic
Genetic Epidemiology: Implications for the Clinical Practitioner

08:45 - 09:30
Mathias Rummel, MD
Universitätsklinik Giessen
Koen van Besien, MD
University of Chicago
Pro-Con: Is there a role for ASCT in follicular lymphoma?

09:30 - 09:50
Break

09:50 - 10:35
Susan O’Brien, MD
MD Anderson Cancer Center
Treatment Options for Newly Diagnosed CLL

10:35 - 11:20
Jorge Romaguera, MD
MD Anderson Cancer Center
Treatment of mantle cell lymphoma:  is upfront aggressive chemotherapy and/or transplant needed?

11:20 - 12:20
Case Discussions
Leo I. Gordon, MD
Northwestern University
Stephanie A. Gregory, MD
Rush University Medical Center
Chadi Nabhan, MD
Lurtheran General Hospital
David J. Peace, MD
University of Illinois
Scott Smith, MD, PhD
Loyola University
Patrick Stiff, MD
Loyola University
Jane N. Winter, MD
Northwestern University

12:20 - 13:15
Lunch

13:15 - 14:05
Michael Crump, MD
Princess Margaret Hospital
Life After Hodgkin Lymphoma: Late Risks and Prevention/Treatment Strategies

14:05 - 15:05
KEYNOTE ADDRESS
Michael Pfreundschuh, MD
Saarland University Medical School
Perspectives on Front-line DLBCL--Current Status and the Future

Adjourn

^ TOP

Hosts:

The University fo Chicago Division of Biological Sciencse DEPARTMENT OF MEDICINE The University of Chicago Cancer Research Center Robert H. Lurie Comprehensive Cancer Center of Northwestern University Northwestern University

Co-sponsored by Northwestern University's Feinberg School of Medicine and the University of Chicago